...
首页> 外文期刊>Stem cell research >Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1 - ScienceDirect
【24h】

Generation of induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient with a p.Ser1457fs mutation in PKD1 - ScienceDirect

机译:源自常染色体显性多囊肾疾病患者的多能干细胞的生成,PKD1中存在p.Ser1457fs突变-ScienceDirect

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Autosomal dominant polycystic kidney disease is one of the most prevalent forms of inherited cystic kidney disease, and can be characterized by kidney cyst formation and enlargement. Here we report the generation of a Type 1 ADPKD disease iPS cell line, IBMS-iPSC-012-12, which retains the conserved deletion of PKD1, normal karyotype and exhibits the properties of pluripotent stem cells such as ES-like morphology, expression of pluripotent markers and capacity to differentiate into all three germ layers. Our results show that we have successfully generated a patient-specific iPS cell line with a mutation in PKD1 for study of renal disease pathophysiology.
机译:常染色体显性遗传性多囊性肾脏疾病是遗传性囊性肾脏疾病的最普遍形式之一,其特征是肾囊肿的形成和增大。在这里,我们报告了1型ADPKD疾病iPS细胞系IBMS-iPSC-012-12的生成,该系保留了PKD1的保守缺失,正常核型,并展现了多能干细胞的特性,例如ES样形态,多能性标志物和分化为所有三个细菌层的能力。我们的结果表明,我们已经成功地产生了患者特异性iPS细胞系,该细胞系具有PKD1突变,用于研究肾脏疾病的病理生理学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号